Patrick Stephen Gallagher - Jun 1, 2022 Form 3 Insider Report for Sensei Biotherapeutics, Inc. (SNSE)

Role: Chief Business Officer
Signature: /s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol: SNSE
Transactions as of: Jun 1, 2022
Transactions value $: $0
Form type: 3
Date filed: 6/3/2022, 04:15 PM
Next filing: Mar 29, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney